CMS plans to cut what Medicare pays hospitals for drugs bought through the 340B program and push site-neutral payment into a new category of outpatient services, two proposals that together would pull billions of dollars out of hospital outpatient revenue…
Pharmacy
St. Catherine Hospital in East Chicago, Ind., recently named Nectaria Bonner, PharmD, CEO. The hospital is part of Munster, Ind.-based Powers Health, which operates four hospitals. Dr. Bonner joined the health system in 2013 as inpatient pharmacy manager at Community…
The Kroger Co. will acquire supermarket chain Giant Eagle, Inc. for $1.65 billion, expanding its pharmacy footprint across northern Ohio, western Pennsylvania, West Virginia, Maryland and Indiana. Giant Eagle operates 11 standalone pharmacies, according to a July 1 news release.…
Amgen has recalled select lots of its heart medication Corlanor and kidney disease treatment Sensipar because of foreign material concerns and current good manufacturing practice deviations. The recall affects multiple lots of Corlanor (ivabradine) 5 milligram and 7.5 milligram tablets,…
Cigna’s Evernorth Health Services announced Pharmacy Forward, an AI-powered program for specialty care, July 1. The program, backed by a $100 million investment through 2028, will first launch with Evernorth’s Accredo Specialty Pharmacy. Pharmacy Forward will integrate clinical data, AI-generated…
Advertisement
AstraZeneca will pay nearly $34 million to resolve allegations it used illegal kickbacks to influence prescriptions reimbursed by Texas Medicaid. Texas sued AstraZeneca under the Texas Health Care Program Fraud Prevention Act, alleging the drugmaker provided free nursing services and…
AIDS Drug Assistance Program Advocacy and the Partnership for Safe Medicines are urging pharmacies to avoid purchasing discounted HIV medications through online pharmacy-to-pharmacy marketplaces, warning the products may qualify as suspect under FDA guidance and the Drug Supply Chain Security…
The New England Journal of Medicine has retracted the clinical trial publication behind Amgen’s rare disease drug Tavneos after two of the study’s authors requested the retraction over undisclosed changes to how patient outcomes were assessed. In a June 29…
The FDA has selected seven companies to participate in its PreCheck Pilot Program, an initiative designed to support domestic pharmaceutical manufacturing through earlier regulatory engagement and a more predictable review process. The FDA first unveiled the PreCheck concept in August…
On July 1, eligible Medicare Part D beneficiaries can access GLP-1 medications — Ozempic, Wegovy, Mounjaro and Zepbound — at a $50 monthly copay through the Medicare GLP-1 Bridge program, a temporary federal initiative running through December 2027. The program…